Alfred A. Jacobs

641 total citations
26 papers, 459 citations indexed

About

Alfred A. Jacobs is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Alfred A. Jacobs has authored 26 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Alfred A. Jacobs's work include Erythropoietin and Anemia Treatment (8 papers), Hemoglobinopathies and Related Disorders (8 papers) and Iron Metabolism and Disorders (5 papers). Alfred A. Jacobs is often cited by papers focused on Erythropoietin and Anemia Treatment (8 papers), Hemoglobinopathies and Related Disorders (8 papers) and Iron Metabolism and Disorders (5 papers). Alfred A. Jacobs collaborates with scholars based in United States, Australia and United Kingdom. Alfred A. Jacobs's co-authors include Michael E. Brier, Adam E. Gawęda, George R. Aronoff, Kenneth R. McLeish, Mehmet K. Muezzinoglu, Jacek M. Żurada, Richard Ward, Samuel R. Wellhausen, N. Shesh and Andrew T. Dailey and has published in prestigious journals such as Biometrics, Biochemical and Biophysical Research Communications and Journal of the American Society of Nephrology.

In The Last Decade

Alfred A. Jacobs

26 papers receiving 443 citations

Peers

Alfred A. Jacobs
Adam E. Gawęda United States
Alan M. Hochberg United States
Pankaj Mathur United States
Silke Roedder United States
D. Wexler Israel
Charles D. Hawker United States
Adam E. Gawęda United States
Alfred A. Jacobs
Citations per year, relative to Alfred A. Jacobs Alfred A. Jacobs (= 1×) peers Adam E. Gawęda

Countries citing papers authored by Alfred A. Jacobs

Since Specialization
Citations

This map shows the geographic impact of Alfred A. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred A. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred A. Jacobs more than expected).

Fields of papers citing papers by Alfred A. Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred A. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred A. Jacobs. The network helps show where Alfred A. Jacobs may publish in the future.

Co-authorship network of co-authors of Alfred A. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred A. Jacobs. A scholar is included among the top collaborators of Alfred A. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred A. Jacobs. Alfred A. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gawęda, Adam E., Alfred A. Jacobs, George R. Aronoff, & Michael E. Brier. (2018). Individualized anemia management in a dialysis facility – long-term utility as a single-center quality improvement experience. Clinical Nephrology. 90(4). 276–285. 15 indexed citations
2.
Gawęda, Adam E., George R. Aronoff, Alfred A. Jacobs, N. Shesh, & Michael E. Brier. (2013). Individualized Anemia Management Reduces Hemoglobin Variability in Hemodialysis Patients. Journal of the American Society of Nephrology. 25(1). 159–166. 42 indexed citations
3.
Brier, Michael E., Adam E. Gawęda, Andrew T. Dailey, George R. Aronoff, & Alfred A. Jacobs. (2010). Randomized Trial of Model Predictive Control for Improved Anemia Management. Clinical Journal of the American Society of Nephrology. 5(5). 814–820. 42 indexed citations
4.
Gawęda, Adam E., Brian H. Nathanson, Alfred A. Jacobs, et al.. (2010). Determining Optimum Hemoglobin Sampling for Anemia Management from Every-Treatment Data. Clinical Journal of the American Society of Nephrology. 5(11). 1939–1945. 19 indexed citations
5.
Gawęda, Adam E., Alfred A. Jacobs, George R. Aronoff, & Michael E. Brier. (2008). Model Predictive Control of Erythropoietin Administration in the Anemia of ESRD. American Journal of Kidney Diseases. 51(1). 71–79. 52 indexed citations
6.
Jacobs, Alfred A., et al.. (2008). Application of fuzzy logic to predicting erythropoietic response in hemodialysis patients. The International Journal of Artificial Organs. 31(12). 1035–1042. 12 indexed citations
7.
Gawęda, Adam E., Mehmet K. Muezzinoglu, George R. Aronoff, et al.. (2007). Using clinical information in goal-oriented learning. IEEE Engineering in Medicine and Biology Magazine. 26(2). 27–36. 2 indexed citations
8.
Gawęda, Adam E., Mehmet K. Muezzinoglu, Alfred A. Jacobs, George R. Aronoff, & Michael E. Brier. (2006). Model Predictive Control with Reinforcement Learning for Drug Delivery in Renal Anemia Management. PubMed. 2006. 5177–5180. 22 indexed citations
9.
Gawęda, Adam E., Mehmet K. Muezzinoglu, Alfred A. Jacobs, George R. Aronoff, & Michael E. Brier. (2006). Model Predictive Control with Reinforcement Learning for Drug Delivery in Renal Anemia Management. Conference proceedings. 3 indexed citations
10.
Gawęda, Adam E., Mehmet K. Muezzinoglu, George R. Aronoff, et al.. (2005). Individualization of pharmacological anemia management using reinforcement learning. Neural Networks. 18(5-6). 826–834. 50 indexed citations
11.
Jacobs, Alfred A., et al.. (2004). Artificial neural network-based pharmacodynamic population analysis in chronic renal failure. 1. 71–74. 1 indexed citations
12.
Gawęda, Adam E., Alfred A. Jacobs, Michael E. Brier, & Jacek M. Zurada. (2003). Pharmacodynamic population analysis in chronic renal failure using artificial neural networks—a comparative study. Neural Networks. 16(5-6). 841–845. 33 indexed citations
13.
Jacobs, Alfred A., et al.. (1995). Chemoattractant receptor-specific differences in G protein activation rates regulate effector enzyme and functional responses. Journal of Leukocyte Biology. 57(4). 679–686. 16 indexed citations
14.
Klein, Jon B., Janice A. Scherzer, George B. Harding, Alfred A. Jacobs, & Kenneth R. McLeish. (1995). TNF-α stimulates increased plasma membrane guanine nucleotide binding protein activity in polymorphonuclear leukocytes. Journal of Leukocyte Biology. 57(3). 500–506. 19 indexed citations
15.
Lederer, Eleanor D., Alfred A. Jacobs, Jerald L. Hoffman, et al.. (1994). Role of Carboxylmethylation in Chemoattractant Receptor-Stimulated G Protein Activation and Functional Responses. Biochemical and Biophysical Research Communications. 200(3). 1604–1614. 10 indexed citations
16.
Lederer, Eleanor D., et al.. (1993). Desensitization by protein kinase C activation differentially uncouples formyl peptide receptors from effector enzymes in HL-60 granulocytes. Cellular Signalling. 5(6). 735–745. 5 indexed citations
17.
McLeish, Kenneth R. & Alfred A. Jacobs. (1993). Rapid Degradation of NAD by Retinoic Acid-Differentiated HL-60 Granulocyte Membranes Prevents ADP Ribosylation. Biochemical and Biophysical Research Communications. 192(2). 870–878. 4 indexed citations
18.
Bowen, David, et al.. (1991). The clearance of a single i.v. bolus of recombinant human erythropoietin from the serum of patients with myelodysplastic syndromes and its effects on erythropoiesis.. PubMed. 19(7). 613–6. 10 indexed citations
20.
Jacobs, Alfred A., Richard Ward, Samuel R. Wellhausen, & Kenneth R. McLeish. (1989). Polymorphonuclear Leukocyte Function during Hemodialysis: Relationship to Complement Activation. ˜The œNephron journals/Nephron journals. 52(2). 119–124. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026